TriSalus Life Sciences's total assets for Q4 2025 were $35.33M, a decrease of -3.10% from the previous quarter. TLSI total liabilities were $69.19M for the fiscal quarter, a 9.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.